CLDX
Price:
$27.02
Market Cap:
$1.79B
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity; CDX-1140, a human agonist monoclonal antibody targeted to CD40, a key activator of immune response, which is found on dendritic cells, macrophages, and B cells, as well as is expressed on various cancer cells; and CDX-527, a bispecific antibody, wh...[Read more]
Industry
Biotechnology
IPO Date
1986-05-15
Stock Exchange
NASDAQ
Ticker
CLDX
According to Celldex Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Celldex Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), CLDX's Dividend Yield was at its highest in in the December 2014 quarter at 0%. The Dividend Yield was at its lowest in in the December 2014 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Celldex Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2023 | 0% | 0% |
2022 | 0% | 0% |
2021 | 0% | 0% |
2020 | 0% | 0% |
2019 | 0% | 0% |
2018 | 0% | 0% |
2017 | 0% | 0% |
2016 | 0% | 0% |
2015 | 0% | 0% |
2014 | 0% | 0% |
The current Dividend Yield of Celldex Therapeutics, Inc. (CLDX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Celldex Therapeutics, Inc.’s Dividend Yield is less than IDEAYA Biosciences, Inc. (0%), less than AnaptysBio, Inc. (0%), less than MeiraGTx Holdings plc (0%), less than Keros Therapeutics, Inc. (0%), less than Homology Medicines, Inc. (0%), less than Cerevel Therapeutics Holdings, Inc. (0%), less than Avidity Biosciences, Inc. (0%), less than Revolution Medicines, Inc. (0%), less than Day One Biopharmaceuticals, Inc. (0%), less than SpringWorks Therapeutics, Inc. (0%), less than Cytokinetics, Incorporated (0%), less than DICE Therapeutics, Inc. (0%), less than Edgewise Therapeutics, Inc. (0%), less than Karuna Therapeutics, Inc. (0%), less than Dyne Therapeutics, Inc. (0%), less than Crinetics Pharmaceuticals, Inc. (0%), less than ALX Oncology Holdings Inc. (0%), less than Immatics N.V. (0%), less than BioAtla, Inc. (0%), less than Aerovate Therapeutics, Inc. (0%), less than Travere Therapeutics, Inc. (0%), less than Ventyx Biosciences, Inc. (0%), less than Cogent Biosciences, Inc. (0%),
Company | Dividend Yield | Market cap |
---|---|---|
0% | $2.32B | |
0% | $677.65M | |
0% | $463.45M | |
0% | $2.27B | |
0% | $3.02M | |
0% | $8.19B | |
0% | $5.16B | |
0% | $9.55B | |
0% | $1.38B | |
0% | $2.90B | |
0% | $5.79B | |
0% | $2.27B | |
0% | $3.05B | |
0% | $12.60B | |
0% | $3.02B | |
0% | $5.20B | |
0% | $74.37M | |
0% | $905.91M | |
0% | $75.90M | |
0% | $76.81M | |
0% | $1.59B | |
0% | $130.81M | |
0% | $1.01B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Celldex Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Celldex Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Celldex Therapeutics, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Celldex Therapeutics, Inc. (CLDX)?
What is the highest Dividend Yield for Celldex Therapeutics, Inc. (CLDX)?
What is the 3-year average Dividend Yield for Celldex Therapeutics, Inc. (CLDX)?
What is the 5-year average Dividend Yield for Celldex Therapeutics, Inc. (CLDX)?
How does the current Dividend Yield for Celldex Therapeutics, Inc. (CLDX) compare to its historical average?